Fox Rothschild LLP

Fox Rothschild LLP, doing business as Fox Rothschild Obrien & Frankel LLP, is a partnership or limited liability partnership registered to receive federal contract awards since July 2017. The firm primarily provides legal services to the federal government, with a focus on patent prosecution, intellectual property management, and litigation support. As a for-profit organization, Fox Rothschild specializes in offering expert legal counsel and representation to various federal agencies, particularly in areas related to technology transfer, patent applications, and eDiscovery services.

Recent federal contract awards to Fox Rothschild demonstrate the firm's expertise in patent legal services and litigation support. The company has been awarded multiple delivery orders by the National Institutes of Health (NIH) for drafting and filing Patent Cooperation Treaty (PCT) applications, performing patent prosecution services, and providing general patent legal support. These awards, ranging from $5,222.50 to $16,900, were issued by the National Heart Lung and Blood Institute and the National Institute of Allergy and Infectious Diseases. Additionally, Fox Rothschild secured a $1,198,108 firm fixed price contract from the Department of Energy's Office of Environmental Management for eDiscovery and litigation support services, with a completion date of February 2025. These contracts highlight the firm's capabilities in managing complex legal matters for federal agencies, particularly in the realms of biomedical research and environmental management.

Fox Rothschild holds a significant indefinite delivery contract (IDV) with the National Institutes of Health for patent legal services. This master IDIQ contract, awarded in April 2020, has a potential value of $386 million and a performance period through April 2024. The contract falls under the NIH Patent Legal Services parent vehicle and covers a wide range of patent-related legal services, including biotechnology, chemistry, mechanical engineering, and software. Under this IDV, Fox Rothschild is expected to handle over 2,500 active patent cases and file approximately 200-300 new applications annually across nine NIH technology transfer centers and government agencies nationwide. The contract's scope demonstrates Fox Rothschild's substantial role in supporting the NIH's biomedical research mission through comprehensive patent prosecution and intellectual property management services.